Margot Lazow is an Oncology physician affiliated with Nationwide Children's Hospital. OpenAlex indexes 82 publications with 1,112 citations (h-index 15); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
700 Childrens Dr
Columbus, OH 432052664
Telephone
614-722-2000Provider last certified this registry record 17 Feb 2026.
Clinical trials
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Sponsor: Nationwide Children's Hospital
- Targeted Pediatric High-Grade Glioma Therapy
Sponsor: Nationwide Children's Hospital
- Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Sponsor: Nationwide Children's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Day One BiopharmaceuticalsProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2022–2025 per NIH RePORTER. The latest:
- Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma
Research Inst Nationwide Children'S Hosp
FY2025$3,218,733R01FD008167 - Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]
Research Inst Nationwide Children'S Hosp
FY2024$485,894R01FD007532 - Phase I/II Study of 177Lu-DOTATATE in Children and Young Adults with Recurrent/Progressive High-Grade CNS Tumors and Meningiomas which Express Somatostatin Type 2A Receptors [9/24/21 IND]
Research Inst Nationwide Children'S Hosp
FY2022$784,837R01FD007532
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Warren Lo, MD
Nationwide Children's Hospital
Maryam Fouladi, MD
Nationwide Children's Hospital
Jerry Mendell, MD
Nationwide Children's Hospital
Anne Connolly, MD
Nationwide Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”